Digg It
#1 in Business Subscribe Email Print

You are here: Home > Finance > Credit > Credit Scores vs FICO Scores - Are They the Same Thing?

Tags

  • drugs
  • accounts
  • product
  • combination products
  • companies involved

  • Links

  • Mortgage Refinancing: How to Refinance Without Overpaying
  • The Basics of Water Soluble Vitamins
  • Border Patrol has NO Balls to Raid Corrupt Carwash Owners
  • Digg It - Credit Scores vs FICO Scores - Are They the Same Thing?

    No they are definitely not the same thing. They serve different purpo
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ses.

    FICO scores were created by Fair Isaac Corporation. They are us
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    d by the mortgage industry to determine the creditworthiness of borrow
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    rs. The score is an indication of how well a mortgage or loan will be
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    repaid by the borrower. High FICO scores are best. Low scores indica
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    te future non-payments. FICO scores primarly provide a guide to futur
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    risk.

    Credit scores, on the other hand, are reported by three nation
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    l credit bureaus - Equifax, Experian and TransUnion. The credit bureau
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    issue reports based on their credit ratings. They are used by many l
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    enders and companies to check up on individuals but are not used prima
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ily for mortgage lending. Credit reports show your current borrowings
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    accounts, status, how you pay your bills, and whether you have opened
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    or closed accounts recently. The report provides data, does not make
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    an judgement on your ability to pay. Credit scores show your historic
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    l credit information and how you paid your bills.

    It is very importan
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    you verify the information contained in this report. Inaccurate info
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    mation can harm you for a long time. Since this information is collec
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ted by the credit bureau and sold to merchants who request information
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    on you, you need to check it yourself once in a while. In the event y
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    u find an error, put it in writing to the credit agency and the lender


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/92113/diggit-Credit-Scores-vs-FICO-Scores--Are-They-the-Same-Thing.html">Credit Scores vs FICO Scores - Are They the Same Thing?</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/92113/diggit-Credit-Scores-vs-FICO-Scores--Are-They-the-Same-Thing.html]Credit Scores vs FICO Scores - Are They the Same Thing?[/url]

    Related Articles:

    The Difference Between Order Takers and Professional Influencers

    Profitable Paper Piecing on eBay--Part 1

    5 Good Reasons For Using Yahoogroups To Start Your Own Ezine

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com